SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
SpyGlass Pharma, Inc. Common StockUS flagNASDAQ Global Market
19.00
USD
-0.15
- -
635.31MMarket Cap

Income Statement (USD)

APIChatGPT
2023 Y
2024 Y
2025 Y
As of date
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- Cost of Revenue
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
Gross Profit
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- Operating Expenses
14
27
41
+ Selling, General & Admin
4
7
12
+ Research & Development
10
20
29
+ Other Operating Expense
- -
- -
- -
Operating Income (Loss)
-14
-27
-41
- Non-Operating (Income) Loss
-1
2
-2
+ Interest Expense, Net
-1
-1
-3
+ Interest Expense
- -
- -
- -
- Interest Income
1
1
3
+ Other Non-Op (Income) Loss
- -
3
2
Pretax Income
-13
-29
-40
- Income Tax Expense (Benefit)
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
Income (Loss) from Cont Ops
-13
-29
-40
- Net Extraordinary Losses (Gains)
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
Income (Loss) Incl. MI
-13
-29
-40
- Minority Interest
- -
- -
- -
Net Income, GAAP
-13
-29
-40
- Preferred Dividends
- -
- -
- -
- Other Adjustments
- -
- -
- -
Net Income Avail to Common, GAAP
-13
-29
-40
EBIT
-14
-27
-41
EBITDA
-14
-27
-41
EBITDA Margin (%)
- -
- -
- -
EBITA
-14
-27
-41
Gross Margin (%)
- -
- -
- -
Operating Margin (%)
- -
- -
- -
Profit Margin (%)
- -
- -
- -
Sales per Employee
- -
- -
- -
Dividend per Share
- -
- -
- -
Depreciation Expense
- -
- -
1
Basic Weighted Avg Shares
11
18
32
Basic EPS, GAAP
-1.17
-1.62
-1.25
Basic EPS from Cont Ops
-1.17
-1.62
-1.25
Diluted Weighted Avg Shares
11
18
32
Diluted EPS, GAAP
-1.17
-1.62
-1.25
Diluted EPS from Cont Ops
-1.17
-1.62
-1.25

Balance Sheet (USD)

APIChatGPT
2023 Y
2024 Y
2025 Y
As of date
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
41
17
109
+ Cash, Cash Equivalents & STI
40
16
107
+ Cash & Cash Equivalents
16
16
96
+ ST Investments
24
- -
11
+ Accounts & Notes Receiv
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
+ Inventories
- -
- -
- -
+ Raw Materials
- -
- -
- -
+ Work In Process
- -
- -
- -
+ Finished Goods
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
+ Other Inventory
- -
- -
- -
+ Other ST Assets
- -
1
1
+ Misc ST Assets
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
Total Noncurrent Assets
1
6
7
+ Property, Plant & Equip, Net
- -
5
4
+ Property, Plant & Equip
1
6
5
- Accumulated Depreciation
- -
1
1
+ LT Investments & Receivables
- -
- -
- -
+ LT Investments
- -
- -
- -
+ LT Receivables
- -
- -
- -
+ Other LT Assets
- -
- -
3
+ Total Intangible Assets
- -
- -
- -
+ Goodwill
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
+ Misc LT Assets
- -
- -
3
Total Assets
41
23
116
+ Payables & Accruals
1
2
3
+ Accounts Payable
1
2
3
+ Accrued Taxes
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
+ ST Debt
- -
- -
- -
+ ST Borrowings
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
+ Other ST Liabilities
1
5
6
+ Deferred Revenue
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
+ Misc ST Liabilities
1
5
6
Total Current Liabilities
2
8
9
+ LT Debt
- -
3
2
+ LT Borrowings
- -
- -
- -
+ LT Finance Leases
- -
3
2
+ Other LT Liabilities
73
73
205
+ Accrued Liabilities
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
+ Misc LT Liabilities
73
73
205
Total Noncurrent Liabilities
73
76
206
Total Liabilities
74
84
215
+ Preferred Equity and Hybrid Capital
- -
- -
- -
+ Share Capital & APIC
3
4
6
+ Common Stock
- -
- -
- -
+ Additional Paid in Capital
3
4
6
- Treasury Stock
- -
- -
- -
+ Retained Earnings
-36
-65
-105
+ Other Equity
- -
- -
- -
Equity Before Minority Interest
-33
-60
-99
+ Minority/Non Controlling Interest
- -
- -
- -
Total Equity
-33
-60
-99
Total Liabilities & Equity
41
23
116
Shares Outstanding
32
32
32
Number of Employees
- -
- -
- -
Capital Leases - Total
- -
4
2
Net Debt
-16
-16
-96
Net Debt to Equity
48.05
26.9
97.49
Tangible Common Equity Ratio
-80.16
-259.34
-85.3
Current Ratio
25.57
2.23
12.67
Cash Conversion Cycle
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2023 Y
2024 Y
2025 Y
As of date
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-13
-29
-40
+ Depreciation & Amortization
- -
- -
1
+ Non-Cash Items
1
6
4
+ Stock-Based Compensation
1
1
3
+ Deferred Income Taxes
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
+ Other Non-Cash Adj
- -
4
1
+ Chg in Non-Cash Work Cap
- -
1
2
+ (Inc) Dec in Accts Receiv
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
- -
+ Inc (Dec) in Accts Payable
- -
2
3
+ Inc (Dec) in Other
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Operating Activities
-12
-22
-33
+ Change in Fixed & Intang
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
-1
+ Increase in Capital Stock
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
-1
+ Net Change in LT Investment
-20
24
-11
+ Dec in LT Investment
14
45
6
+ Inc in LT Investment
-34
-21
-17
+ Net Cash From Acq & Div
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
+ Cash for JVs
- -
- -
- -
+ Other Investing Activities
- -
-2
-1
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Investing Activities
-20
22
-12
+ Dividends Paid
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
+ Cash From Debt
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
+ Other Financing Activities
40
- -
126
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Financing Activities
40
- -
125
Effect of Foreign Exchange Rates
- -
- -
- -
Net Changes in Cash
7
- -
80
EBITDA
-14
-27
-41
EBITDA Margin (%)
- -
- -
- -
Free Cash Flow
-12
-22
-33
Net Cash Paid for Acquisitions
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
Free Cash Flow to Equity
- -
-22
-33
Free Cash Flow per Basic Share
-1.08
-1.23
-1.02
Price/Free Cash Flow
- -
- -
- -
Cash Flow to Net Income
0.92
0.76
0.82
Capital Expenditures
- -
- -
- -